Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for MediWound (MDWD) over the last 11 years, with Q3 2025 value amounting to $13.0 million.

  • MediWound's Other Non-Current Liabilities fell 3189.02% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year decrease of 3189.02%. This contributed to the annual value of $17.1 million for FY2024, which is 65762.41% up from last year.
  • As of Q3 2025, MediWound's Other Non-Current Liabilities stood at $13.0 million, which was down 3189.02% from $19.0 million recorded in Q2 2025.
  • MediWound's 5-year Other Non-Current Liabilities high stood at $19.1 million for Q3 2024, and its period low was $2.3 million during Q4 2023.
  • For the 5-year period, MediWound's Other Non-Current Liabilities averaged around $10.3 million, with its median value being $11.3 million (2023).
  • As far as peak fluctuations go, MediWound's Other Non-Current Liabilities crashed by 8554.4% in 2023, and later surged by 65762.41% in 2024.
  • Quarter analysis of 5 years shows MediWound's Other Non-Current Liabilities stood at $3.9 million in 2021, then surged by 297.91% to $15.6 million in 2022, then plummeted by 85.54% to $2.3 million in 2023, then surged by 657.62% to $17.1 million in 2024, then dropped by 24.06% to $13.0 million in 2025.
  • Its Other Non-Current Liabilities was $13.0 million in Q3 2025, compared to $19.0 million in Q2 2025 and $12.8 million in Q1 2025.